Search research articles
Contact Us
Filters
Showing results (1161-1170 of 1,174) with videos related to
Page
of 118
Sort By:
European Journal of Preventive Cardiology
|
November 13, 2025
Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE study
Chantal F Ski, Catriona S Jennings, Dirk De Bacquer, et al.
Journal of the American College of Cardiology
|
April 8, 2024
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction
Jacob A Udell, Mark C Petrie, W Schuyler Jones, et al.
Heart (British Cardiac Society)
|
March 26, 2026
Prevalence and characteristics of patients with coronary heart disease and blood pressure below target: the INTERASPIRE study
John P McCormick, Dirk De Bacquer, Catriona Jennings, et al.
International Journal of Cardiology
|
May 21, 2026
Female sex is independently associated with poor health-related quality of life in patients with coronary heart disease across 14 countries: the INTERASPIRE study
Chantal F Ski, David R Thompson, Catriona S Jennings, et al.
JAMA
|
March 29, 2020
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
Mark C Petrie, Subodh Verma, Kieran F Docherty, et al.
The New England Journal of Medicine
|
September 20, 2019
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, et al.
Cardiovascular Diabetology
|
August 12, 2025
Global detection and management of dysglycaemic patients with coronary artery disease results from the INTERASPIRE survey from 14 countries across six WHO regions
Safi Moayad Al-Azzawy, John William McEvoy, Isabelle Johansson, et al.
Journal of the American College of Cardiology
|
April 1, 2026
Chronic Kidney Disease Screening in Patients With Coronary Heart Disease: The Multinational INTERASPIRE Study
Safi Moayad Al-Azzawy, Dirk De Bacquer, John William McEvoy, et al.
Global Heart
|
September 8, 2025
Cardiac Rehabilitation in Patients with Coronary Heart Disease - Provision, Attendance, and Outcomes: Results from the INTERASPIRE Survey from Fourteen Countries Across Six WHO Regions
Kornelia Kotseva, Dirk De Bacquer, Catriona Jennings, et al.
Journal of the American College of Cardiology
|
May 28, 2025
Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease: Insights From the INTERASPIRE Study and Implications for Emerging Lp(a)-Lowering Therapies
Fotios Barkas, Julia Brandts, Dirk De Bacquer, et al.
Page
of 118
Search research articles
Search
Showing results (1161-1170 of 1,174) with videos related to
Sort By:
Page
of 118
European Journal of Preventive Cardiology
|
November 13, 2025
Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE study
Chantal F Ski, Catriona S Jennings, Dirk De Bacquer, et al.
Journal of the American College of Cardiology
|
April 8, 2024
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction
Jacob A Udell, Mark C Petrie, W Schuyler Jones, et al.
Heart (British Cardiac Society)
|
March 26, 2026
Prevalence and characteristics of patients with coronary heart disease and blood pressure below target: the INTERASPIRE study
John P McCormick, Dirk De Bacquer, Catriona Jennings, et al.
International Journal of Cardiology
|
May 21, 2026
Female sex is independently associated with poor health-related quality of life in patients with coronary heart disease across 14 countries: the INTERASPIRE study
Chantal F Ski, David R Thompson, Catriona S Jennings, et al.
JAMA
|
March 29, 2020
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
Mark C Petrie, Subodh Verma, Kieran F Docherty, et al.
The New England Journal of Medicine
|
September 20, 2019
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, et al.
Cardiovascular Diabetology
|
August 12, 2025
Global detection and management of dysglycaemic patients with coronary artery disease results from the INTERASPIRE survey from 14 countries across six WHO regions
Safi Moayad Al-Azzawy, John William McEvoy, Isabelle Johansson, et al.
Journal of the American College of Cardiology
|
April 1, 2026
Chronic Kidney Disease Screening in Patients With Coronary Heart Disease: The Multinational INTERASPIRE Study
Safi Moayad Al-Azzawy, Dirk De Bacquer, John William McEvoy, et al.
Global Heart
|
September 8, 2025
Cardiac Rehabilitation in Patients with Coronary Heart Disease - Provision, Attendance, and Outcomes: Results from the INTERASPIRE Survey from Fourteen Countries Across Six WHO Regions
Kornelia Kotseva, Dirk De Bacquer, Catriona Jennings, et al.
Journal of the American College of Cardiology
|
May 28, 2025
Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease: Insights From the INTERASPIRE Study and Implications for Emerging Lp(a)-Lowering Therapies
Fotios Barkas, Julia Brandts, Dirk De Bacquer, et al.
Page
of 118